Acceptance Rate:
Time from acceptance to publication:
24 days*
Impact Factor (JCR):
2023 Total content views:
2023 Total Altmetric mentions:

Aims and scope

BMJ Open Diabetes Research & Care is an open access diabetes journal committed to publishing high-quality basic and clinical research articles regarding type 1 and type 2 diabetes and associated symptoms, complications, and treatments. Submissions are subject to rigorous external peer review to ensure the publication of high-quality information. The online-only format allows for continuous updates and serves as an invaluable resource to the multidisciplinary community of endocrinology, public health/prevention and internal medicine. A rapid review process will also ensure that timely, up-to-date research is available internationally. BMJ Open Diabetes Research & Care is published by BMJ in partnership with the American Diabetes Association.

Editorial board

For information about BMJ Open Diabetes Research & Care Editor-in-Chief Mandeep Bajaj and his editorial team, please refer to the Editorial Board page.


BMJ Open Diabetes Research & Care is owned by BMJ.

Journal information

Publication Model
Open access
Launch Date
Digital Archives
Indexed by
Web of Science Core Collection: Science Citation Index Expanded, Emerging Sources Citation Index; MEDLINE (Index Medicus), PubMed Central, Scopus, Embase (Excerpta Medica), DOAJ, Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author

Journal Statistics 2023

Acceptance rate: 16%
Speed Time to first decision without review: 5 days (median) Time to first decision with review: 42 days (median) Time from acceptance to publication: 24 days (median)
Impact Impact Factor category: Endocrinology & Metabolism Impact Factor (JCR): 4.1 Impact Factor rank (JCR): 56/145 5 Year Impact Factor: 4.2 Journal Citation Indicator: 0.9 Eigenfactor Score: 0.00982 Citescore: 3.5 Citescore rank: 43/130 SciMago Journal Rank (SJR): 0.913
Reach 2023 total content views: 458,035 2023 total Altmetric mentions: 1,325
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics


Online advertising – USA and Canada only
Jim Cunningham jcunningham@cunnasso.com Tel: +1 201.767.4170 Fax: +1 201.767.8065
Online advertising – All countries except USA and Canada


Founded in 1940, the American Diabetes Association funds research to prevent, cure and manage diabetes, and among its many activities delivers services to hundreds of communicates and advocates on behalf of those affected by the disease. www.diabetes.org
Dryad is an international repository of data underlying peer-reviewed articles in the basic and applied biosciences. Dryad enables scientists to validate published findings, explore new analysis methodologies, repurpose data for research questions unanticipated by the original authors, and perform synthetic studies. BMJ has been working with Dryad since 2010.
The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. BMJ is a sponsor of its activities.
The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. BMJ has been a member since 2009.
All BMJ Open Diabetes Research & Care articles are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) licence. These licenses let others distribute, remix, tweak and build upon your work. See our open access page for more details.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results.